A phase II trial of bryostatin-1 administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinoma. [electronic resource]
Producer: 20031125Description: 1152-4 p. digitalISSN:- 0007-0920
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Bryostatins
- Disease Progression
- Enzyme Activation
- Female
- Humans
- Infusions, Intravenous
- Lactones -- administration & dosage
- Macrolides
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasms, Glandular and Epithelial -- drug therapy
- Ovarian Neoplasms -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.